PI3K/AKT signaling has been identified as a key driver of cellular proliferation, migration, and angiogenesis in human tumorigenesis, including medulloblastoma, in which activation of PI3K/AKT signaling enhances tumor growth, metastasis, and chemoresistance [23–25]. This evidence concerns the gene AKT1 and medulloblastoma.